Reduction in soluble guanylyl cyclase-specific activity following prolonged treatment of porcine pulmonary artery with nitric oxide
Authors:
- William J. PerkinsWPWilliam J. Perkins
- Miwa TaniguchiMTMiwa Taniguchi
- David O. WarnerDWDavid O. Warner
- Eduardo N. ChiniECEduardo N. Chini
- Keith A. JonesKJKeith A. Jones
Open Access
- 1 July 2007
- journal article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 293 (1) , L84-L95
Abstract
In a newly characterized cultured porcine pulmonary artery (PA) preparation, 24-h treatment with the nitric oxide (NO) donor ( Z)-1-[ N-(2-aminoethyl)- N-(2-ammonioethyl)amino]diazen-1-ium-1,2-diolate (DETA-NO) decreased the response to acutely applied DETA-NO compared with 24-h control (−log EC506.55 ± 0.12 and 5.02 ± 0.21, respectively). Treatment of PA with the cell-permeable superoxide dismutase mimetic, Mn(III) tetra(4-benzoic acid) porphyrin chloride, did not change NO responsiveness in either freshly prepared or 24-h DETA-NO-treated PA. cGMP and cAMP phosphodiesterase activities were approximately equal in PA. Twenty-four-hour DETA-NO treatment did not change either cGMP or cAMP phosphodiesterase activities. Twenty-four hours in culture had no significant effect on soluble guanylyl cyclase (sGC) subunit mRNA expression, but 24-h DETA-NO treatment significantly decreased the expression of both sGCα1and sGCβ1. sGCβ1protein expression was 42 ± 4 ng/mg soluble protein. Twenty-four hours in culture without and with DETA-NO reduced sGCβ1protein expression (36 ± 3 and 31 ± 3 ng/mg soluble protein, respectively, P < 0.025). Basal tissue cGMP [(cGMP)i] was significantly increased, and NO-induced (cGMP)iwas significantly decreased by 24-h DETA-NO treatment. (cGMP)inormalized to the amount of sGC protein expressed in PA was significantly lower in PA treated for 24 h with DETA-NO compared with both freshly isolated and 24-h cultured PA. We conclude that prolonged NO treatment induces decreased acute NO responsiveness in part by decreasing both sGC expression and sGC-specific activity.Keywords
This publication has 57 references indexed in Scilit:
- Prolonged relaxation consistent with persistent soluble guanylyl cyclase activation in canine pulmonary artery following brief treatment with nitric oxide donorsLife Sciences, 2006
- Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vesselsJournal of Clinical Investigation, 2006
- Spare guanylyl cyclase NO receptors ensure high NO sensitivity in the vascular systemJournal of Clinical Investigation, 2006
- NO responsiveness in pulmonary artery and airway smooth muscle: the role of cGMP regulationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Increased Nitrovasodilator Sensitivity in Endothelial Nitric Oxide Synthase Knockout MiceHypertension, 2000
- Validation of Lucigenin as a Chemiluminescent Probe to Monitor Vascular Superoxide as Well as Basal Vascular Nitric Oxide ProductionBiochemical and Biophysical Research Communications, 1999
- Enhanced Endothelium-Dependent Relaxations After Gene Transfer of Recombinant Endothelial Nitric Oxide Synthase to Rabbit Carotid ArteriesHypertension, 1997
- Regulation of Vascular Smooth Muscle Growth by α1-Adrenoreceptor Subtypes in Vitro and in SituJournal of Biological Chemistry, 1995
- Evidence for enhanced vascular superoxide anion production in nitrate tolerance. A novel mechanism underlying tolerance and cross-tolerance.Journal of Clinical Investigation, 1995
- Molecular cloning of the cDNAs coding for the two subunits of soluble guanylyl cyclase from human brainFEBS Letters, 1992